These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15109023)

  • 21. Nanoparticles: A personal experience for formulating poorly water soluble drugs.
    Cooper ER
    J Control Release; 2010 Feb; 141(3):300-2. PubMed ID: 19822177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of spray-drying and electrospraying/electospinning for poorly water-soluble drugs: a particle engineering approach.
    Bohr A; Boetker JP; Rades T; Rantanen J; Yang M
    Curr Pharm Des; 2014; 20(3):325-48. PubMed ID: 23651398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Particle design of poorly water-soluble drug substances using supercritical fluid technologies.
    Yasuji T; Takeuchi H; Kawashima Y
    Adv Drug Deliv Rev; 2008 Feb; 60(3):388-98. PubMed ID: 18068261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrospun nanofibers in oral drug delivery.
    Ignatious F; Sun L; Lee CP; Baldoni J
    Pharm Res; 2010 Apr; 27(4):576-88. PubMed ID: 20143253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug nanoparticles: formulating poorly water-soluble compounds.
    Merisko-Liversidge EM; Liversidge GG
    Toxicol Pathol; 2008 Jan; 36(1):43-8. PubMed ID: 18337220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients.
    Vogt M; Kunath K; Dressman JB
    Eur J Pharm Biopharm; 2008 Feb; 68(2):330-7. PubMed ID: 17574401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanosuspensions of poorly water soluble drugs prepared by top-down technologies.
    Zhang X; Li LC; Mao S
    Curr Pharm Des; 2014; 20(3):388-407. PubMed ID: 23651400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of the solubility parameter concept to assist with oral delivery of poorly water-soluble drugs - a PEARRL review.
    Jankovic S; Tsakiridou G; Ditzinger F; Koehl NJ; Price DJ; Ilie AR; Kalantzi L; Kimpe K; Holm R; Nair A; Griffin B; Saal C; Kuentz M
    J Pharm Pharmacol; 2019 Apr; 71(4):441-463. PubMed ID: 29978475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate.
    Dai WG; Dong LC; Song YQ
    Int J Pharm; 2007 Sep; 342(1-2):201-7. PubMed ID: 17560055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Poorly Soluble Drugs' Dissolution Rate by Laser Scattering in Different Water Isotopologues.
    Uspenskaya EV; Pleteneva TV; Kazimova IV; Syroeshkin AV
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33498881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanocrystals Technology for Pharmaceutical Science.
    Cheng Z; Lian Y; Kamal Z; Ma X; Chen J; Zhou X; Su J; Qiu M
    Curr Pharm Des; 2018; 24(21):2497-2507. PubMed ID: 29773056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review.
    Kumar S; Bhargava D; Thakkar A; Arora S
    Crit Rev Ther Drug Carrier Syst; 2013; 30(3):217-56. PubMed ID: 23614647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical cocrystals and poorly soluble drugs.
    Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
    Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoglyceride-based self-assembling copolymers as carriers for poorly water-soluble drugs.
    Rouxhet L; Dinguizli M; Latere Dwan'isa JP; Ould-Ouali L; Twaddle P; Nathan A; Brewster ME; Rosenblatt J; Ariën A; Préat V
    Int J Pharm; 2009 Dec; 382(1-2):244-53. PubMed ID: 19666096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of nanosuspension formulations on transport, pharmacokinetics, in vivo targeting and efficacy for poorly water-soluble drugs.
    Wang Y; Miao X; Sun L; Song J; Bi C; Yang X; Zheng Y
    Curr Pharm Des; 2014; 20(3):454-73. PubMed ID: 23651402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melt extrusion with poorly soluble drugs - An integrated review.
    Repka MA; Bandari S; Kallakunta VR; Vo AQ; McFall H; Pimparade MB; Bhagurkar AM
    Int J Pharm; 2018 Jan; 535(1-2):68-85. PubMed ID: 29102700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Counter-intuitive enhancement in the dissolution of indomethacin with the incorporation of cohesive poorly water-soluble inorganic salt additives.
    Tay T; Allahham A; Morton DA; Stewart PJ
    Eur J Pharm Biopharm; 2011 Nov; 79(3):674-82. PubMed ID: 21703348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticulate strategies for effective delivery of poorly soluble therapeutics.
    Gokce EH; Ozyazici M; Souto EB
    Ther Deliv; 2010 Jul; 1(1):149-67. PubMed ID: 22816125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery.
    Brough C; Williams RO
    Int J Pharm; 2013 Aug; 453(1):157-66. PubMed ID: 23751341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.